Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
about
Protein nanoparticles as drug delivery carriers for cancer therapyTargeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects.In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliveryUptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier modelBSA nanoparticle loaded atorvastatin calcium--a new facet for an old drugTracking of magnetite labeled nanoparticles in the rat brain using MRIEnhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cellsSynthetic nanoparticles of bovine serum albumin with entrapped salicylic acidEncapsulating gold nanomaterials into size-controlled human serum albumin nanoparticles for cancer therapy platforms.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).Nanoparticulate transport of oximes over an in vitro blood-brain barrier model.Smart Release Nano-formulation of Cytochrome C and Hyaluronic Acid Induces Apoptosis in Cancer Cells.Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.Activation of caspase-dependent apoptosis by intracellular delivery of Cytochrome c-based nanoparticles.The preparation and characterization of folate-conjugated human serum albumin magnetic cisplatin nanoparticles.STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cellsNanotechnology in oncology: Characterization and in vitro release kinetics of cisplatin-loaded albumin nanoparticles: Implications in anticancer drug delivery.Human serum albumin-based nanoparticle-mediated in vitro gene deliveryComparison of Different Crosslinking Methods for Preparation of Docetaxel-loaded Albumin NanoparticlesTargeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles.Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment.A novel albumin nanocomplex containing both small interfering RNA and gold nanorods for synergetic anticancer therapy.A redox-sensitive micelle-like nanoparticle self-assembled from amphiphilic adriamycin-human serum albumin conjugates for tumor targeted therapy.Antinociceptive, muscle relaxant and sedative activities of gold nanoparticles generated by methanolic extract of Euphorbia miliiSilylated precision particles for controlled release of proteins.Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid.Engineering of near IR fluorescent albumin nanoparticles for in vivo detection of colon cancerA toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy.Non-viral therapeutic approaches to ocular diseases: An overview and future directionsBiopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Preparation of ultrasound microbubbles crosslinked to albumin nanoparticles packaged with tissue-type plasminogen activator gene plasmid and method of in vivo transfection.A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release studyBovine serum albumin nanoparticles with fluorogenic near-IR-emitting squaraine dyes.Suppression of agglomeration of ciprofloxacin-loaded human serum albumin nanoparticles.Protein-based fluorescent nanoparticles for super-resolution STED imaging of live cells.Challenges in development of nanoparticle-based therapeutics.Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.
P2860
Q23923552-771D4A07-44CB-41E2-94EA-7949ED8EADE7Q27310025-13707932-030D-4F2D-A602-2EA5EA56F973Q28396006-A041B553-3D4E-4482-8299-F7F098029E11Q28481345-36F10C76-3D65-4766-AFE9-8265CBE98F88Q28539424-5987184E-F8BD-4FA3-B631-953C3E6F6C6BQ28540929-6B8629DA-7CEE-43EA-AA82-7EDF737ADA73Q28544700-07ABF41E-7C62-4CB6-84B9-E805C9C6225CQ28818198-16D6A5E2-E3E2-4FC4-87BD-CFFE1DD590ECQ30365411-A89C1AE3-0581-4230-A71B-4A1755EF9943Q30366990-8C341F29-3159-489E-B6BF-8FD3D6CD4441Q33572988-4968EB1D-40F8-4224-87E4-1539A1B0095CQ33769616-38A540D7-449A-4108-81D7-ACEDAA3A7222Q33894458-C59F2187-9A82-41B8-8E0A-3ABEB66491C3Q34280232-D8EC5208-0879-4B0C-813A-97D2BAFC43B4Q34544795-E93B96B6-7DCB-42AD-8A7D-3CA2E12280A2Q34647693-A51A45B3-7F3E-415B-A811-F1587CFECFF7Q35031755-5767EFCA-7435-4534-96BD-CF0DA34DF6B5Q35157105-3BE3F623-FB32-4985-B9AA-85591B7EA1D2Q35258046-C8C1963D-79C0-4A71-8BF9-AB711471ABCCQ35483895-8BA98D35-DBE5-42A2-9783-9CBF08918798Q35483911-7764C6A0-E7C7-4E6F-BD26-677B680EA5BEQ35609201-D76BEF45-E312-4681-90ED-C1E991D1B6A9Q35619130-19591FAB-8422-4681-A431-FED4C62E9597Q35649616-0F7432C4-6D45-4473-92AF-C36EB0845867Q35658525-F2A20780-17DC-4F56-872E-A034F0F5F16FQ35983600-8350C08C-F6C9-42C6-BE9F-CD772BE63665Q36015949-8446BD9F-8377-4857-B1B4-7E25637EB7F9Q36335016-02C30F97-F53F-4578-A090-BC2FDA217E5CQ36391010-E2AD4158-376A-4960-9128-84DA105EB7D2Q36425890-E74BD158-456C-44F9-B35F-0A073EF4A6D0Q36590092-C82B1D74-C69C-472C-9B6A-314D44DEDFD5Q36890456-9B89CDA4-9AF7-4654-88E2-524620040DA6Q37042592-269752F9-5D82-4398-A107-26F2BC74AF46Q37065965-56459A6F-15D6-4E53-AAD0-7ECCFC21F811Q37287068-B1F73915-C206-48D1-8281-E7B35B2F5773Q37360699-8881EFFE-A69E-42D5-924D-534D67A11C97Q37724914-A70C5C01-199B-489F-99ED-4C621988BE37Q37992525-39E2D8E5-77AF-414B-B082-9D17CC712B4BQ38024311-53E4EE07-0034-48F4-96C8-B2AA67A201C0Q38067265-7AF5E7B0-0611-4B4C-9422-0286EE7009B9
P2860
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
@ast
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
@en
type
label
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
@ast
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
@en
prefLabel
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
@ast
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
@en
P2093
P1476
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
@en
P2093
D Schubert
H von Briesen
S Balthasar
P304
P356
10.1016/S0378-5173(03)00134-0
P407
P50
P577
2003-05-01T00:00:00Z